Revive Therapeutics Ltd (RVV.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Accounts receivable | 37 | -20 | 71 | -54 | -6 |
| Other Working Capital | -2,384 | 2,831 | 89 | 164 | 380 |
| Other Operating Activity | -3,278 | -4,628 | -2,643 | -3,760 | -1,578 |
| Operating Cash Flow | $-5,624 | $-1,817 | $-2,483 | $-3,649 | $-1,204 |
| Cash Flows From Investing Activities | |||||
| Other Investing Activity | 0 | 0 | 0 | -3,000 | 0 |
| Investing Cash Flow | $N/A | $N/A | $0 | $-3,000 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 38 | 38 | 58 | 38 | N/A |
| Debt Repayment | -38 | -38 | -37 | -37 | -74 |
| Common Stock Issued | N/A | 35 | 7,656 | N/A | N/A |
| Other Financing Activity | 105 | 0 | -7,617 | 21,295 | 1,978 |
| Financing Cash Flow | $105 | $35 | $59 | $21,295 | $1,903 |
| Beginning Cash Position | 14,818 | 16,600 | 19,024 | 4,378 | 3,397 |
| End Cash Position | 9,299 | 14,818 | 16,600 | 19,024 | 4,378 |
| Net Cash Flow | $-5,519 | $-1,782 | $-2,424 | $14,646 | $981 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,624 | -1,817 | -2,483 | -3,649 | -1,204 |
| Free Cash Flow | -5,624 | -1,817 | -2,483 | -3,649 | -1,204 |